This content is machine translated Multiple sclerosis Mastering challenges in everyday practice The therapeutic landscape for multiple sclerosis is now broad. Nevertheless, the goal of neuroprotective and remyelinating therapy has not yet been achieved. The aim of the 37th Congress of the…
View Post 2 min This content is machine translated Migraine Escaping the grip of pain – effective therapy makes it possible Migraine is based on a complex pathophysiology, which could only be detected gradually. According to current knowledge, a genetic predisposition, certain triggers, stress or overwork can trigger the recurring headache…
View Post 4 min This content is machine translated Methylphenidate Treatment of apathy in Alzheimer’s disease To date, there is no causal therapy for Alzheimer’s dementia approved in Europe. This makes the treatment of accompanying symptoms all the more important. Here, the focus is particularly on…
View Post 3 min This content is machine translated Updated and expanded guideline “Neurological manifestations in COVID-19.” Neurological manifestations and complications of COVID-19 require rapid diagnosis and therapy as an emergency indication. The updated guideline of the German Society of Neurology (DGN), Berlin, “Neurological manifestations in COVID-19”…
View Post 4 min This content is machine translated Voice frequency modulation Alexa, am I getting Parkinson’s? Various disease-modifying therapies for Parkinson’s disease are expected in the coming years, but it is already known: These therapies probably only have the potential to halt the progression of the…
View Post 4 min This content is machine translated Neurology New forms of care: Neurology on the road to the future This year’s online congress of the DGN was again a great success. 6700 attendees followed the live program, where 170 speakers presented their papers on site and discussed with each…
View Post 6 min This content is machine translated Multiple sclerosis Diroximelfumarate impresses with improved gastrointestinal tolerability [1,2] Diroximel fumarate/DRF is a novel oral fumarate for patients with relapsing-remitting multiple sclerosis (RRMS) that was granted health insurance approval in Switzerland on November 1, 2021, and has been available…
View Post 6 min This content is machine translated Migraine therapy and prophylaxis Things to know for the family doctor Headaches are one of the main issues in family practice today, which is why patients seek medical advice. Migraine, in particular, is widespread. Several epidemiological studies demonstrate its high prevalence…
View Post 3 min This content is machine translated Neurology A highly dynamic subject of the future Neurology is one of the most progressive fields in medicine – and its development has been rapid. Milestones include the first approved gene therapy for spinal muscular atrophy, deep brain…
View Post 4 min This content is machine translated Amyotrophic lateral sclerosis (ALS) Risk factor heavy physical work Researchers at Ulm University Medical Center have identified heavy physical labor as a risk factor for the incurable nerve disease amyotrophic lateral sclerosis (ALS). In their technical publication, which is…
View Post 3 min This content is machine translated Tetanus toxin The first active ingredient against muscle loss Stroke, multiple sclerosis or spinal cord injuries are among the most common neurological diseases in which permanent paralysis and muscle atrophy can result from a disorder in the central nervous…
